Expansion of HIV-1 screening and anti-retroviral treatment programs in a resource-poor setting: Results from a faith-based organization in Jos, Plateau State, Nigeria

African Health Sciences

Volumn 7, Issue 2, 2007, Pages 93-100

  Hillary, Lum ^a   Isichei, Christian ^b,d   Isichei Wakili, Mercy ^b   Redfield, Robert ^c  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF JOS   (Nigeria)

^c INSTITUTE OF HUMAN VIROLOGY   (United States)

^d Institute of Human Virology ^*

Author keywords

ART program; HIV; Nigeria; Resource poor

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE; EFAVIRENZ; EFAVIRENZ PLUS LAMIVUDINE PLUS STAVUDINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVIR; LAMIVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; NEVIRAPINE; STAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ASSESSMENT; DISEASE CLASSIFICATION; FEMALE; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH PROGRAM; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOLISTIC CARE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL CARE; MORTALITY; NIGERIA; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; PATIENT COUNSELING; PRACTICE GUIDELINE; RETROSPECTIVE STUDY; TREATMENT DURATION; VOLUNTEER; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANTI-RETROVIRAL AGENTS; CHILD; FEMALE; HEALTH RESOURCES; HIV INFECTIONS; HIV-1; HUMANS; MALE; MASS SCREENING; NIGERIA; ORGANIZATIONS, NONPROFIT; RELIGION;

EID: 34547794643     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Report of 1995/96 HIV Sentinel Sero-surveillance in Nigeria. Federal Ministry of Health, National AIDS/STD Control Programme. May 1997, Abuja, Nigeria.
2. A Technical report on the 2001 National HIV/Syphilis Sentinel Survey mong pregnant women attending Antenatal clinics in Nigeria. Federal Ministry of Health, National AIDS/STD Control Programme. December 2001,Abuja, Nigeria.
3. 2003 National HIV Sero-prevalence Sentinel Survey. Federal Ministry of Health, National AIDS/STD Control Programme. April 2004,Abuja, Nigeria.
4. Sagay AS, Kapiga SH, Imade GE, et al. HIV infection among pregnant women in Nigeria. Int J of Gyn and Ob. 2005; 90:61-7.
5. Idigbe EO, Adewole TA, Eisen G, et al. Management of HIV-1 infection with a combination of nevirapine, stavudine, and lamivudine: a preliminary report on the Nigerian antiretroviral program. JAIDS. 2005; 40:65-9.
6. Harries AD, Gomani P, Teck R, et al. Monitoring the response to antiretroviral therapy in resource-poor settings: the Malawi model. Trans Royal Soc Trop Med and Hygiene. 2004; 98:695-701.
7. Kumarasamy N, Chaguturu SK, Majan AP, et al. Safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in South India. AIDS. 2003; 17:2267-2269.
8. Stringer JS, Zulu I, Levy J, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA. 2006 Aug 16;296(7):782-93.
9. Zachariah R,Teck R, Buhendwa L, et al. Community support is associated with better antiretroviral treatment outcomes in a resource-limited rural district in Malawi. Trans R Soc Trop Med Hyg. 2007 Jan; 101(1):79-84.
10. World Health Organization. Guidelines on co-trimaxazole prophylaxis for HIV-related infections among children, adolescents and adults. Available at http://www.who.int/hiv/pub/guidelines/ctx/en/index.html. Accessed on January 18, 2007.
11. WHO/UNAIDS/IAS. Safe and Effective Use of Antiretroviral Treatment in AdultsWith Particular Reference to Resource Limited Settings. P. Munderi, E. Prag, and S. Vella, eds. Geneva, Switzerland:WHO/AIS; 2000:1-31.
12. Ferradini L, Jeannin A, Pinoges L, et al. Scaling up of highly active antiretroviral therapy in a rural district of Malawi: an effectiveness assessment. Lancet. 2006 Apr 22;367(9519):1335-42.
13. Aina O, Dadik J, Charurat M, et al. Reference Values of CD4T Lymphocytes in Human Immunodeficiency virus-Negative Adult Nigerians. Clin Diag Lab Imm. 2005; 12: 525-530.
14. Braitstein P, Brinkhof MW, Dabis F, et al. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income counties. Lancet. 2006; 367:817-24.
15. Ivers LC, Kendrick D, and Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings; a meta-analysis of the published literature. Clin Infect Dis. 2005; 41:217-24.